Dietary fats, carbohydrates and vascular disease: Sri Lankan perspectives

Atherosclerosis

Volumn 171, Issue 2, 2003, Pages 157-161

  Abeywardena, Mahinda Y ^a  

^a CSIRO   (Australia)

Author keywords

Cardiovascular disease; Diet; Endothelium; Novel biomarkers; Sri Lanka

Indexed keywords

CARBOHYDRATE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DAMAGE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FAT INTAKE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MORTALITY; OXIDATIVE STRESS; PARTICLE SIZE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SRI LANKA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0344896682     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00157-6     Document Type: Review

References (33)

1. Mendis S. Cardiovascular research in Sri Lanka - a review and bibliography, Colombo, Sri Lanka: Ministry of Health, 1998:1-135.
2. Mendis S., Samarajeewa U., Thattil R.O. Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats. Br. J. Nutr. 85:2001;583-589.
3. Haumann B.F. Lauric oils have their own niche. Inform. 3:1992;1080-1093.
4. Changbumrung S., Buavatana T., Migasena P. Alpha-tocopherol in vegetable oils. Int. J. Vitamin Nutr. Res. 50:1980;242-246.
5. American Heart Association, Summary of the scientific conference on dietary fatty acids and cardiovascular health. Circulation 2001;103:1034-9.
6. Perera A., Atukorale D.N., Sivayogan S., et al. Prevalence of skin diseases in suburban Sri Lanka. Ceylon Med. J. 45:2000;123-128.
7. Lands WEM. Fish and human health, London: Academic Press, 1986:20-5.
8. Riccardi G., Rivellese A.A. Dietary treatment of the metabolic syndrome - the optimal diet. Br. J. Nutr. 83:2000;S143-8.
9. Barton M., Carmona R., Krieger J.E., et al. Endothelin regulates angiotensin-converting enzyme in the mouse kidney. J. Cardiovasc. Pharmacol. 36:2000;S244-247.
10. Arechaga G., Martinez J.M., Prieto I., et al. Serum aminopeptidase A activity of mice is related to dietary fat saturation. J. Nutr. 131:2001;1177-1179.
11. Reaux A., Iturrioz X., Vazeux G., et al. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in the central control of arterial blood pressure. Biochem. Soc. Trans. 28:2000;435-440.
12. Lee J.Y., Sohn K.H., Rhee S.H., et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276:2001;16683-16689.
13. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2:2001;282-286.
14. Mendis S., Arseculeratne Y.M., Withana N., et al. Chlamydia pneumoniae infection and its association with coronary heart disease and cardiovascular risk factors in a sample South Asian population. Int. J. Cardiol. 79:2001;191-196.
15. Mendis S., Athauda S.B., Nase M., Takahashi K., et al. Association between hyperhomocysteinaemia and hypertension in Sri Lankans. J. Int. Med. Res. 27:1999;38-44.
16. Lefebvre P.J., Scheen A.J. The postprandial state and risk of cardiovascular disease. Diabetic Med. 15:1998;S63-68.
17. Jagla A., Schrezenmeir J. Postprandial triglycerides and endothelial function. Exp. Clin. Endocrinol. Diabetes. 109:2001;S533-547.
18. Hennig B., Toborek M., McClain C.J. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J. Am. Coll. Nutr. 20:2001;97-105.
19. Brown A.A., Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am. J. Clin. Nutr. 73:2001;673-686.
20. Abeywardena M.Y., Head R.J. n-3 Polyunsaturated fatty acids and blood vessel function. Cardiovasc. Res. 52:2001;361-371.
21. Lichtenstein A.H., Van Horn L. Very low fat diets - American Heart Association Science advisory report. Circulation. 98:1998;935-939.
22. Reaven G.M. Diet and Syndrome X. Curr. Atheroscler. Rep. 2:2000;503-507.
23. Popkin BM, Horton S, Kim S. The nutritional transition and diet-related chronic diseases in Asia-Implication for prevention, International Food Policy Research Institute, 2001; FCND-Discussion paper No. 105; http://www.ifpriorg/ checknames.cfm/fcndp105.pdfname=fcndp105.pdfadirec=d:\webs\ifpri\divs\fcnd\dp\ papers .
24. Simmons D., Williams R. Dietary practises among Europeans and different South Asian groups in Coventry. Br. J. Nutr. 78:1997;5-14.
25. Weerasuriya N., Siribaddana S., Dissanayake A., et al. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. Q. J. Med. 91:1998;439-443.
26. Fernando D.J., Siribaddana S., Perera N., et al. The prevalence of macrovascular disease and lipid abnormalities amongst diabetic patients in Sri Lanka. Postgrad. Med. J. 69:1993;557-561.
27. Duplain H., Burcellin R., Satori C., et al. Insulin resistance, hyperlipidemia and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 4:2001;342-345.
28. Kurowska E.M. Nitric oxide therapies in vascular diseases. Curr. Pharm. Des. 8:2002;155-166.
29. Miyazaki H., Matsuoka H., Cooke J.P., et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 99:1999;1141-1146.
30. Cooke J.P. Does ADMA cause endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 20:2000;2032-2037.
31. Valkonen V.P., Oaiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 358:2001;2127-2128.
32. Stulingher M.C., Abbasi F., Chu J.W., et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. J. Am. Med. Assoc. 287:2002;1420-1426.
33. Narasinga Rao B.S. Palm oil use and compatibility in India. Food Nutr. Bull. 15:1994;149-157.